Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Medical Condition: Cystic Fibrosis MedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Cystic+Fibrosis+MedDRA+version%3A+20.0Level%3A+PTClassification+code+10011762Term%3A+Cystic+fibrosisSystem+Organ+Class%3A+10010331+-+Congenital%2C+familial+and+genetic+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Cystic+Fibrosis+MedDRA+version%3A+20.0Level%3A+PTClassification+code+10011762Term%3A+Cystic+fibrosisSystem+Organ+Class%3A+10010331+-+Congenital%2C+familial+and+genetic+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Cystic+Fibrosis+MedDRA+version%3A+20.0Level%3A+PTClassification+code+10011762Term%3A+Cystic+fibrosisSystem+Organ+Class%3A+10010331+-+Congenital%2C+familial+and+genetic+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (84)
1
A study to assess the efficacy and safety of a combination of two experimental drugs in people with cystic fibrosis (a rare hereditary lung disease) : A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long term Treatment With VX 661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del CFTR Mutation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A study to assess the efficacy and safety of a combination of two experimental drugs in people with cystic fibrosis (a rare hereditary lung disease) : A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long term Treatment With VX 661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del CFTR Mutation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Evaluation of Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are 6 Years of Age and Older : A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445/TEZ/IVA Combination Therapy in Subjects With Cystic Fibrosis Who Are 6 Years of Age and Older
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Phase 3 Study of VX-121 Combination Therapy in Subjects With Cystic Fibrosis : A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Evaluation of Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are 6 Years of Age and Older : A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445/TEZ/IVA Combination Therapy in Subjects With Cystic Fibrosis Who Are 6 Years of Age and Older
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Phase 3 Study of VX-121 Combination Therapy in Subjects With Cystic Fibrosis : A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor Long-term Safety and Efficacy in Subjects Without F508del : A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes - Study to Evaluate Elx/Tez/Iva Long-term Safety and Efficacy in Subjects Without F508del
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis Subjects 1 Through 11 Years of Age : A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX-121/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Through 11 Years of Age
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Phase 3 Study of VX-121 Combination Therapy in Subjects With Cystic Fibrosis : A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor Long-term Safety and Efficacy in Subjects Without F508del : A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes - Study to Evaluate Elx/Tez/Iva Long-term Safety and Efficacy in Subjects Without F508del
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
Nächster »
[9]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Medical Condition: Cystic Fibrosis MedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Medienart
84
Aufsätze
84
E-Artikel
84
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
84
610
Medical Condition: Cystic Fibrosis MedDRA versi...
84
Recruitment Status: Authorised-recruitment may ...
84
Study Type: Interventional
82
Phase: Phase 3
2
Phase: Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
82
2020-
2
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
84
Englisch
Haven't found what you're looking for?
Wird geladen...